Search

8 result(s) for 'author#Allan Wiik' within BMC

1. The clinical and the laboratory autoimmunologist: Where do we stand?

   Authors: Renato Tozzoli and Nicola Bizzaro

   Citation: Autoimmunity Highlights 2020 11:10

   Content type: Editorial Published on: 7 July 2020

   • View Full Text
   • View PDF

2. Thank you to Virology Journal’s peer reviewers in 2012

   The editors of Virology Journal would like to thank all our reviewers who have contributed to the journal in Volume 9 (2012). The success of any scientific journal depends on an effective and strict peer review p...

   Authors: Linfa Wang

   Citation: Virology Journal 2013 10:44

   Content type: Reviewer acknowledgement Published on: 20 February 2013

   • View Full Text
   • View PDF

3. Clinical and laboratory characteristics of drug-induced vasculitic syndromes

   Clinical recognition of drug-induced vasculitic and lupus-like syndromes is very important because continued use of the offending drug can lead to irreversible and life-threatening vasculitic organ damage (e.g...

   Authors: Allan Wiik

   Citation: Arthritis Research & Therapy 2005 7:191

   Content type: Commentary Published on: 24 August 2005

   • View Full Text
   • View PDF

4. The use of citrullinated peptides and proteins for the diagnosis of rheumatoid arthritis

   The presence or absence of antibodies to citrullinated peptides/proteins (ACPA) is an important parameter that helps a clinician set a diagnosis of early rheumatoid arthritis and, hence, initiate treatment. Th...

   Authors: Ger JM Pruijn, Allan Wiik and Walther J van Venrooij

   Citation: Arthritis Research & Therapy 2010 12:203

   Content type: Review Published on: 15 February 2010

   • View Full Text
   • View PDF

5. Environmental risk factors differ between rheumatoid arthritis with and without auto-antibodies against cyclic citrullinated peptides

   The aim of this study was to evaluate new and previously hypothesised non-genetic risk factors for serologic subtypes of rheumatoid arthritis (RA) defined by the presence or absence of auto-antibodies to cycli...

   Authors: Merete Pedersen, Søren Jacobsen, Mette Klarlund, Bo V Pedersen, Allan Wiik, Jan Wohlfahrt and Morten Frisch

   Citation: Arthritis Research & Therapy 2006 8:R133

   Content type: Research article Published on: 27 July 2006

   • View Full Text
   • View PDF

6. The use and abuse of commercial kits used to detect autoantibodies

   The detection of autoantibodies in human sera is an important approach to the diagnosis and management of patients with autoimmune conditions. To meet market demands, manufacturers have developed a wide variet...

   Authors: Marvin J Fritzler, Allan Wiik, Mark L Fritzler and Susan G Barr

   Citation: Arthritis Res Ther 2003 5:192

   Content type: Review Published on: 9 June 2003

   • View Full Text
   • View PDF

7. Missing links in high quality diagnostics of inflammatory systemic rheumatic diseases

   The aim of this review is to focus attention on high quality diagnostics of systemic inflammatory rheumatic diseases. Though many steps in the diagnostic process from the first visit in a doctor’s office till ...

   Authors: Allan S. Wiik and Nicola Bizzaro

   Citation: Autoimmunity Highlights 2012 3:29

   Content type: Review Article Published on: 11 April 2012

   • View Full Text
   • View PDF

8. Methotrexate and anti-tumor necrosis factor treatment improves endothelial function in patients with inflammatory arthritis

   Inflammatory arthritis (IA), including rheumatoid arthritis (RA), ankylosing spondylitis (AS) and psoriatic arthritis (PsA), leads to increased cardiovascular disease occurrence probably due to atherosclerosis...

   Authors: Gia Deyab, Ingrid Hokstad, Jon Elling Whist, Milada Cvancarova Smastuen, Stefan Agewall, Torstein Lyberg, Nicoletta Ronda, Knut Mikkelsen, Gunnbjorg Hjeltnes and Ivana Hollan

   Citation: Arthritis Research & Therapy 2017 19:232

   Content type: Research article Published on: 17 October 2017

   • View Full Text
   • View PDF